Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02747303 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv12
  2. Trial status: Suspended to Recruiting
    • Primary completion date: Aug 22, 2024 to Aug 22, 2028
    • Study completion date: Aug 22, 2025 to Aug 22, 2028
    • Site details revised
    v11
  3. Secondary endpoints: details revised at 2 of 10 entriesv10
  4. Trial status: Recruiting to Suspended Sponsor's reason: Internal admin issuesv9 Show 5 more changesShow less
    • Start date: Jun 10, 2016 to Sep 5, 2023
    • Primary completion date changed from estimate of May 10, 2026 to Aug 22, 2024
    • Study completion date: May 10, 2026 to Aug 22, 2025
    • Secondary endpoints: details revised at 10 of 10 entries
    • Site details revised
  5. Primary completion date: May 10, 2022 to May 10, 2026v8
Show 6 earlier versionsHide 6 earlier versions
  1. Primary completion date: May 10, 2021 to May 10, 2022v7
  2. Primary completion date: May 2020 to May 10, 2021
    • Study completion date: May 2026 to May 10, 2026
    • Start date: Jun 2016 to Jun 10, 2016
    v6
  3. Study completion date: May 2020 to May 2026
    • Secondary endpoints: 1 to 10
    • Study description shortened, about 200 words
    • Eligibility criteria expanded, about 5 words
    v5
  4. Primary completion date: May 2018 to May 2020
    • Study completion date: May 2020
    • Site contact updated
    • Study title shortened, about 15 words
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: May 2016 to Jun 2016
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized study to determine if not treating planning target volume (PTV) margins during radiation therapy worsens progression free survival rates in patients with brain metastases.
Trial Details
NCT Number NCT02747303
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Brain Metastases
Related terms Brain Neoplasms
Enrollment 166 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov